Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: Interactions between dose, environment, and neuronal phenotype

Journal of Neurochemistry

Volumn 85, Issue 1, 2003, Pages 105-114

  Uslaner, Jason M ^a   Norton, Camille S ^b   Watson, Stanley J ^b   Akil, Huda ^b   Robinson, Terry E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Context; Enkephalin; Fos; Gene expression; Striatum; Substance P

Indexed keywords

AMPHETAMINE; MESSENGER RNA; PREPROENKEPHALIN; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENVIRONMENTAL FACTOR; MALE; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; SENSITIZATION; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

ANIMALIA; EUKARYOTA;

EID: 0037380923     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01646.x     Document Type: Article

References (88)

1. Akaike A., Ohno Y., Sasa M. and Takaori S. (1987) Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res. 418, 262-272.
2. Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
3. Alburges M. E., Keefe K. A. and Hanson G. R. (2001) Contrasting responses by basal ganglia met-enkephalin systems to low and high doses ofmethamphetamine in a rat model. J. Neurochem. 76, 721-729.
4. Arnauld E., Jeantet Y., Arsaut J. and Demotes-Mainard J. (1996) Involvement of the caudal striatum in auditory processing: c-fos response to cortical application of picrotoxin and to auditory stimulation. Mol. Brain Res. 41, 27-35.
5. Badiani A., Anagostaras S. G. and Robinson T. E. (1995a) The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology 117, 443-452.
6. Badiani A., Browman K. E. and Robinson T. E. (1995b) Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res. 674, 291-298.
7. Badiani A., Camp D. M. and Robinson T. E. (1997) Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli. J. Pharmacol. Exp. Ther. 282, 787-794.
8. Badiani A., Oates M. M., Day H. E., Watson S. J., Akil H. and Robinson T. E. (1998) Amphetamine-induced behavior, dopamine release and c-fos mRNA expression: modulation by environmental novelty. J. Neurosci. 18, 10579-10593.
9. Badiani A., Oates M. M., Day H. E., Watson S. J., Akil H. and Robinson T. E. (1999) Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav. Brain Res. 103, 203-209.
10. Banks K. E. and Gratton A. (1995) Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function. Eur. J. Pharmacol. 282, 157-167.
11. Berke J. D., Paletzki R. F., Aronson G. J., Hyman S. E. and Gerfen C. R. (1998) A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18, 5301-5310.
12. Berretta S., Robertson H. A. and Graybiel A. M. (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68, 767-777.
13. Berretta S., Robertson H. A. and Graybiel A. M. (1993) Neurochemically specialized projection neurons of the striatum respond differentially to psychomotor stimulants. Prog. Brain Res. 99, 201-205.
14. Berretta S., Parthasarathy H. B. and Graybiel A. M. (1997) Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci. 17, 4752-4763.
15. Browman K. E., Badiani A. and Robinson T. E. (1998a) The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dose-dependent. Psychopharmacology 137, 90-98.
16. Browman K. E., Badiani A. and Robinson T. E. (1998b) Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. J. Pharmacol. Exp. Ther. 287, 1007-1014.
17. Butcher S. P., Fairbrother I. S., Kelly J. S. and Arbuthnott G. W. (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50, 346-355.
18. Campbell G. A., Eckardt M. J. and Weight F. F. (1985) Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333, 261-270.
19. Canteras N. S., Shammah-Lagnado S. J., Silva B. A. and Ricardo J. A. (1990) Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513, 43-59.
20. Cenci M. A., Campbell K., Wictorin K. and Bjorklund A. (1992) Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia-nigra in the rat. Eur. J. Neurosci. 4, 376-380.
21. Chiodo L. A. and Berger T. W. (1986) Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum. Brain Res. 375, 198-203.
22. Crombag H. S., Badiani A. and Robinson T. E. (1996) Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res. 722, 227-231.
23. Crossman A. R. (1990) A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov. Disord. 5, 100-108.
24. Cullinan W. E., Herman J. P., Battaglia D. F., Akil H. and Watson S. J. (1995) Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64, 477-505.
25. Curran E. J. and Watson S. J. Jr (1995) Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361, 57-76.
26. Day H. E., Badiani A., Uslaner J. M., Oates M. M., Vittoz N. M., Robinson T. E., Watson S. J. Jr and Akil H. (2001) Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J. Neurosci. 21, 732-740.
27. Eichler A. J. and Antelman S. M. (1979) Sensitization to amphetamine and stress may involve nucleus accumbens and medial frontal cortex. Brain Res. 176, 412-416.
28. Eichler A. J., Antelman S. M. and Black C. A. (1980) Amphetamine stereotypy is not a homogeneous phenomenon: sniffing and licking show distinct profiles of sensitization and tolerance. Psychopharmacology 68, 287-290.
29. Falk J. L. and Feingold D. A. (1987) Environmental and cultural factors in the behavioral actions of drugs, in Psychopharmacology: the Third Generation of Progress (Meltzer H. Y., ed.), pp. 1503-1510. Raven Press, New York.
30. Ferguson S. M., Norton C. S., Watson S. J., Akil H. and Robinson T. E. (2002) Role of DA and NMDA receptors in amphetamine-evoked c-fos expression in two distinct striatal cell populations. Soc. Neurosci. Abstr. 812.5.
31. Gardiner T. W., Iverson D. A. and Rebec G. V. (1988) Heterogeneous responses of neostriatal neurons to amphetamine in freely moving rats. Brain Res. 463, 268-274.
32. Gerfen C. R. and Young W. S. (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
33. Gerfen C. R., Miyachi S., Paletzki R. and Brown P. (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22, 5042-5054.
34. Graybiel A. M., Moratalla R. and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87, 6912-6916.
35. Hanson G. R., Bush L., Keefe K. A. and Alburges M. E. (2002) Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine. J. Neurochem. 82, 1171-1178.
36. Harlan R. E. and Garcia M. M. (1998) Drugs of abuse and immediateearly genes in the forebrain. Mol. Neurobiol. 16, 221-267.
37. Hassani O. K., Francois C., Yelnik J. and Feger J. (1997) Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749, 88-94.
38. Hu X. T. and Wang R. Y. (1988) Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study. J. Neurosci. 8, 4340-4348.
39. Hu X. T. and White F. J. (1997) Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neurosci. Lett. 224, 61-65.
40. Hu X. T., Wachtel S. R., Galloway M. P. and White F. J. (1990) Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. J. Neurosci. 10, 2318-2329.
41. Hyman S. E. and Malenka R. C. (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695-703.
42. Ishida Y., Todaka K., Kuwahara I., Ishizuka Y., Hashiguchi H., Nishimori T. and Mitsuyama Y. (1998) Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease. Brain Res. 809, 107-114.
43. Jaber M., Cador M., Dumartin B., Normand E., Stinus L. and Bloch B. (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65, 1041-1050.
44. Johansson B., Lindstrom K. and Fredholm B. B. (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59, 837-849.
45. Kiyatkin E. A. and Rebec G. V. (1996) Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J. Neurophysiol. 75, 142-153.
46. Klebaur J. E., Ostrander M. M., Norton C. S., Watson S. J., Akil H. and Robinson T. E. (2002) The ability of amphetamine to evoke arc (Arg 3.1) mRNA expression in the caudate, nucleus accumbens and neocortex is modulated by environmental context. Brain Res. 930, 30-36.
47. Kosofsky B. E., Genova L. M. and Hyman S. E. (1995) Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J. Comp. Neurol. 351, 41-50.
48. Kreiss D. S., Anderson L. A. and Walters J. R. (1996) Apomorphine and dopamine D(1) receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience 72, 863-876.
49. Kreiss D. S., Mastropietro C. W., Rawji S. S. and Walters J. R. (1997) The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 17, 6807-6819.
50. Maurice N., Deniau J. M., Glowinski J. and Thierry A. M. (1998) Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J. Neurosci. 18, 9539-9546.
51. Mintz I., Hammond C. and Feger J. (1986) Excitatory effect of ionto-phoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res. 375, 172-175.
52. Moratalla R., Elibol B., Vallejo M. and Graybiel A. M. (1996) Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147-156.
53. Nguyen T. V., Kosofsky B. E., Birnbaum R., Cohen B. M. and Hyman S. E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl Acad. Sci. USA 89, 4270-4274.
54. Ni Z., Gao D., Bouali-Benazzouz R., Benabid A. L. and Benazzouz A. (2001) Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur. J. Neurosci. 14, 373-381.
55. Nicola S. M., Surmeier J. and Malenka R. C. (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23, 185-215.
56. Nisenbaum E. S., Orr W. B. and Berger T. W. (1988) Evidence for two functionally distinct subpopulations of neurons within the rat striatum. J. Neurosci. 8, 4138-4150.
57. Ohno M., Yoshida H. and Watanabe S. (1994) NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Brain Res. 665, 135-140.
58. Olds M. E., Jacques D. B. and Kopyov O. (1998) Globus pallidus lesions depress the excitatory responses to apomorphine but not amphetamine in the subthalamic nucleus of the behaving rat with a 6-OHDA nigra lesion. Brain Res. 812, 50-64.
59. Ostrander M. M., Day H. E., Badiani A., Akil H., Watson S. J. and Robinson T. E. (2000) Environmental novelty and past drug history interact to modulate amphetamine-induced c-fos mRNA expression. Soc. Neurosci. Abstr. 484. 1.
60. Overton P. G., Richards C. D., Berry M. S. and Clark D. (1999) Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons. Neuroreport 10, 221-226.
61. Parent A. and Hazrati L. N. (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20, 128-154.
62. Parthasarathy H. B. and Graybiel A. M. (1997) Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci. 17, 2477-2491.
63. Pierce R. C. and Kalivas P. W. (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25, 192-216.
64. Rebec G. V. and Curtis S. D. (1983) Reciprocal changes in the firing rate of neostriatal and dorsal raphe neurons following local infusions or systemic injections of D-amphetamine: evidence for neostriatal heterogeneity. J. Neurosci. 3, 2240-2250.
65. Robinson T. E., Becker J. B., Moore C. J., Castaneda E. and Mittleman G. (1985) Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res. 343, 374-377.
66. Robinson T. E., Browman K. E., Crombag H. S. and Badiani A. (1998) Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci. Biobehav. Rev. 22, 347-354.
67. Ruskin D. N. and Marshall J. F. (1994) Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 18, 233-240.
68. Ruskin D. N. and Marshall J. F. (1995) D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res. 703, 156-164.
69. Segal D. S. (1975) Behavioral and neurochemical correlates of repeated d-amphetamine administration. Adv. Biochem. Psychopharmacol. 13, 247-262.
70. Segal D. S. and Mandell A. J. (1974) Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2, 249-255.
71. Sgambato V., Abo V., Rogard M., Besson M. J. and Deniau J. M. (1997) Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81, 93-112.
72. Sharp T., Zetterstrom T., Ljungberg T. and Ungerstedt U. (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401, 322-330.
73. Smith I. D. and Grace A. A. (1992) Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12, 287-303.
74. Snyder-Keller A. M. (1991) Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113, 155-165.
75. Steiner H. and Gerfen C. R. (1995) Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J. Comp. Neurol. 353, 200-212.
76. Svenningsson P. and Le Moine C. (2002) Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors. Eur. J. Neurosci. 15, 133-142.
77. Taylor M., Goudie A. J., Mortimore S. and Wheeler T. J. (1974) Comparison between behaviours elicited by high doses of amphetamine and fenfluramine: implications for the concept of stereotypy. Psychopharmacologia 40, 249-258.
78. Uslaner J., Badiani A., Day H. E., Watson S. J., Akil H. and Robinson T. E. (2001a) Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res. 920, 106-116.
79. Uslaner J., Badiani A., Norton C. S., Day H. E., Watson S. J., Akil H. and Robinson T. E. (2001b) Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur. J Neurosci. 13, 1977-1983.
80. Vanderschuren L. J. and Kalivas P. W. (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151, 99-120.
81. Vezina P. and Stewart J. (1990) Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516, 99-106.
82. Wagstaff J. D., Gibb J. W. and Hanson G. R. (1996) Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther 278, 547-554.
83. Wang J. Q. and McGinty J. F. (1996) Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors. Brain Res. Bull. 39, 349-357.
84. Wang J. Q., Daunais J. B. and McGinty J. F. (1994) NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18, 343-353.
85. Wirtshafter D. and Asin K. E. (1999) Unilateral dopamine depletion paradoxically enhances amphetamine-induced Fos expression in basal ganglia output structures. Brain Res. 824, 81-88.
86. Wolf M. E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720.
87. Yoshida H., Ohno M. and Watanabe S. (1995) Roles of dopamine D1 receptors in striatal fos protein induction associated with methamphetamine behavioral sensitization in rats. Brain Res. Bull. 38, 393-397.
88. Zheng P., Zhang X. X., Bunney B. S. and Shi W. X. (1999) Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 91, 527-535.